Albinda, Jay Ann T.
HRN: 24-72-29 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2026
CO-AMOXICLAV 625MG (TAB)
01/31/2026
02/07/2026
PO
625mg
BID X 7 Days
S/P Partial Breech Extraction With Episiotomy
Checking Initial Appropriateness